<?xml version="1.0" encoding="UTF-8"?>
<p> Smallpox survivors are known to acquire lifelong immunity against the disease. VACV vaccination provided effective protection against this especially dangerous infection; however, re-vaccination was required to maintain a reliable level of protection against smallpox for a long period of time [
 <xref rid="R1" ref-type="bibr">1</xref>]. In this regard, it is noteworthy that the causative smallpox agent, VARV, lacks at least four genes in its genome, the removal of which enhances the antiviral immune response, which involves various molecular mechanisms (
 <italic>
  <xref rid="T3" ref-type="table">Table 3</xref>
 </italic>). 
</p>
